News Focus
News Focus
Followers 3160
Posts 967887
Boards Moderated 152
Alias Born 09/04/2000

Re: mick post# 226158

Monday, 11/30/2020 9:25:32 AM

Monday, November 30, 2020 9:25:32 AM

Post# of 246423
$SONN Sonnet BioTherapeutics Announces the Completion of a Successful Non-Human Primate Study of SON-1010
Mon, November 30, 2020, 6:30 AM MST
Compared to recombinant human IL-12, SON-1010 demonstrated an enhanced pharmacokinetic (PK) profile that was similar to IgG antibodies

SON-1010 continues to be well tolerated at doses far exceeding levels expected in potential future clinical trials, without producing detectable cytokine imbalances

Analysis of Interferon-? levels, a key biomarker of antitumor activity, suggest potent on-target pharmacodynamic (PD) effects

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today